SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-035590
Filing Date
2015-05-07
Accepted
2015-05-07 16:14:24
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-6940_110q.htm 10-Q 814129
2 EX-31.1 a15-6940_1ex31d1.htm EX-31.1 13506
3 EX-31.2 a15-6940_1ex31d2.htm EX-31.2 12738
4 EX-32.1 a15-6940_1ex32d1.htm EX-32.1 7615
  Complete submission text file 0001104659-15-035590.txt   4208712

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rigl-20150331.xml EX-101.INS 567751
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rigl-20150331.xsd EX-101.SCH 32661
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rigl-20150331_cal.xml EX-101.CAL 41866
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rigl-20150331_lab.xml EX-101.LAB 269927
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rigl-20150331_pre.xml EX-101.PRE 190461
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rigl-20150331_def.xml EX-101.DEF 91150
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 15841919
SIC: 2834 Pharmaceutical Preparations